These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 39113692)

  • 1. Lipid homeostasis in diabetic kidney disease.
    Wang Y; Liu T; Wu Y; Wang L; Ding S; Hou B; Zhao H; Liu W; Li P
    Int J Biol Sci; 2024; 20(10):3710-3724. PubMed ID: 39113692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of renal lipid accumulation in diabetic kidney disease.
    Fang Z; Liu R; Xie J; He JC
    J Cell Mol Med; 2024 Jun; 28(11):e18364. PubMed ID: 38837668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F
    Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipophagy: A Potential Therapeutic Target for Diabetic Nephropathy.
    Yang M; Song P; Zhao L; Wang X
    Curr Med Chem; 2023; 30(16):1875-1886. PubMed ID: 35894456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease.
    Nicholson RJ; Pezzolesi MG; Summers SA
    Front Endocrinol (Lausanne); 2020; 11():622692. PubMed ID: 33584550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipin-1 deficiency deteriorates defect of fatty acid β-oxidation and lipid-related kidney damage in diabetic kidney disease.
    Lin S; Wang L; Jia Y; Sun Y; Qiao P; Quan Y; Liu J; Hu H; Yang B; Zhou H
    Transl Res; 2024 Apr; 266():1-15. PubMed ID: 37433392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid metabolism disorder in diabetic kidney disease.
    Han YZ; Du BX; Zhu XY; Wang YZ; Zheng HJ; Liu WJ
    Front Endocrinol (Lausanne); 2024; 15():1336402. PubMed ID: 38742197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease.
    Ducasa GM; Mitrofanova A; Fornoni A
    Curr Diab Rep; 2019 Nov; 19(12):144. PubMed ID: 31754839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy.
    Herman-Edelstein M; Scherzer P; Tobar A; Levi M; Gafter U
    J Lipid Res; 2014 Mar; 55(3):561-72. PubMed ID: 24371263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities.
    Opazo-Ríos L; Mas S; Marín-Royo G; Mezzano S; Gómez-Guerrero C; Moreno JA; Egido J
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of lipid stores and metabolism by lipophagy.
    Liu K; Czaja MJ
    Cell Death Differ; 2013 Jan; 20(1):3-11. PubMed ID: 22595754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipophagy and liver disease: New perspectives to better understanding and therapy.
    Zhang Z; Yao Z; Chen Y; Qian L; Jiang S; Zhou J; Shao J; Chen A; Zhang F; Zheng S
    Biomed Pharmacother; 2018 Jan; 97():339-348. PubMed ID: 29091883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome.
    Rong J; Zhang Z; Peng X; Li P; Zhao T; Zhong Y
    Int J Biol Sci; 2024; 20(12):4783-4798. PubMed ID: 39309427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy.
    Zhou Y; Liu L; Jin B; Wu Y; Xu L; Chang X; Hu L; Wang G; Huang Y; Song L; Zhang T; Wang Y; Xiao Y; Zhang F; Shi M; Liu L; Wang T; Yan R; Guo B
    Diabetes; 2023 May; 72(5):611-626. PubMed ID: 36812572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Contribution of Lipotoxicity to Diabetic Kidney Disease.
    Schelling JR
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling.
    Zhong D; Chen J; Qiao R; Song C; Hao C; Zou Y; Bai M; Su W; Yang B; Sun D; Jia Z; Sun Y
    Cell Rep; 2024 Apr; 43(4):114075. PubMed ID: 38583151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of protein kinase STK25 ameliorates renal lipotoxicity and protects against diabetic kidney disease.
    Cansby E; Caputo M; Gao L; Kulkarni NM; Nerstedt A; Ståhlman M; Borén J; Porosk R; Soomets U; Pedrelli M; Parini P; Marschall HU; Nyström J; Howell BW; Mahlapuu M
    JCI Insight; 2020 Dec; 5(24):. PubMed ID: 33170807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia.
    Chae SY; Kim Y; Park CW
    Antioxidants (Basel); 2023 Dec; 12(12):. PubMed ID: 38136203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney.
    Hou Y; Tan E; Shi H; Ren X; Wan X; Wu W; Chen Y; Niu H; Zhu G; Li J; Li Y; Wang L
    Cell Mol Life Sci; 2024 Jan; 81(1):23. PubMed ID: 38200266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid droplets and fatty acid-induced lipotoxicity: in a nutshell.
    Obaseki E; Adebayo D; Bandyopadhyay S; Hariri H
    FEBS Lett; 2024 May; 598(10):1207-1214. PubMed ID: 38281809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.